Search Results 3611-3620 of 35392 for oral

1. Thyroid cancer - Doctors and departments - Mayo Clinic

   iation therapy, Hypopharyngeal cancer, Oral and throat cancer, Salivary gland cancer, Thyroid cancer, Head and neck cancer, Skin cancer, Prostate cancer ...

2. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

3. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

4. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

   Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

5. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

6. Accelerating Gastrointestinal Recovery - Clinical Trials

   This study is designed to determine whether an oral perioperative medication (alvimopan--a selective mu antagonist) improves bowel recovery over placebo after ...

7. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

8. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

   combined (estrogen- and progestogen-containing) or progestogen-only hormonal contraception associated with inhibition of ovulation (oral contraceptive pill ...

9. A Study To Evaluate KIN-2787 In Participants With BRAF And/or NRAS Mutation Positive Solid Tumors - Mayo Clinic

   * Able to swallow, retain, and absorb oral medications. Exclusion Criteria ... * GI tract disease causing an inability to take oral medication ...

10. Study To Evaluate The Safety, Tolerability & Efficacy Of TNG462 In Combination In PDAC & NSCLC Patients - Mayo Clinic

    ... oral TNG462 in combination with RMC-6236 or RMC-9805. The study comprises a ... oral medications 8. Has known or suspected active or untreated CNS ...